首页 > 最新文献

ISRN Pharmaceutics最新文献

英文 中文
Labeling of tannic Acid with technetium-99m for diagnosis of stomach ulcer. 用锝-99m标记单宁酸诊断胃溃疡。
Pub Date : 2011-01-01 Epub Date: 2011-07-19 DOI: 10.5402/2011/578570
I T Ibrahim, M El-Tawoosy, H M Talaat

Tannic acid is a polyphenolic compound that could be labeled with technetium-99m. To produce about 90% yield of  (99m)Tc-tannic acid in acidic media (pH), the conditions required were 150 μg tin chloride, 30 min reaction time, and 200 μg of the substrate. (99m)Tc-tannic was stable for 6 h. Oral biodistribution of (99m)Tc-tannic showed that it concentrated in the stomach ulcer to reach about 50% of the total injected dose at 1 h after orall administration. This concentration of (99m)Tc-tannic in stomach ulcer may be sufficient to radio-image the presence of ulcer in the stomach.

单宁酸是一种多酚类化合物,可以用锝-99m标记。为了在酸性介质(pH)中产生约90%的(99m) tc -单宁酸,所需条件为氯化锡150 μg,反应时间30 min,底物200 μg。(99m) tc -单宁在6 h内稳定。(99m)Tc-tannic的口服生物分布表明,在给药后1 h, Tc-tannic在胃溃疡集中,达到总注射剂量的50%左右。胃溃疡中(99m)的tc -单宁浓度可能足以对胃溃疡的存在进行影像学检查。
{"title":"Labeling of tannic Acid with technetium-99m for diagnosis of stomach ulcer.","authors":"I T Ibrahim,&nbsp;M El-Tawoosy,&nbsp;H M Talaat","doi":"10.5402/2011/578570","DOIUrl":"https://doi.org/10.5402/2011/578570","url":null,"abstract":"<p><p>Tannic acid is a polyphenolic compound that could be labeled with technetium-99m. To produce about 90% yield of  (99m)Tc-tannic acid in acidic media (pH), the conditions required were 150 μg tin chloride, 30 min reaction time, and 200 μg of the substrate. (99m)Tc-tannic was stable for 6 h. Oral biodistribution of (99m)Tc-tannic showed that it concentrated in the stomach ulcer to reach about 50% of the total injected dose at 1 h after orall administration. This concentration of (99m)Tc-tannic in stomach ulcer may be sufficient to radio-image the presence of ulcer in the stomach.</p>","PeriodicalId":14802,"journal":{"name":"ISRN Pharmaceutics","volume":"2011 ","pages":"578570"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/578570","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30505771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formulation and evaluation of controlled-release tablet of zolpidem tartrate by melt granulation technique. 采用熔融制粒技术配制和评估酒石酸唑吡坦控释片剂。
Pub Date : 2011-01-01 Epub Date: 2011-06-27 DOI: 10.5402/2011/208394
Shailesh T Prajapati, Amit N Patel, Chhagan N Patel

The present investigation describes the influence of the concentration of PEG 6000 as a melt binder and ratio of HPMC K4M : PVP on Zolpidem tartrate controlled-release tablet formulations using 3(2) full factorial design. The ratio of HPMC K4M and PVP K30 (X(1)) and the concentration of melt binder (X(2)) were selected as independent variables, and drug release at 1 hr (Q(1)), 4 hr (Q(4)), 8 hr (Q(8)), diffusion coefficient (n), and release rate constant (K) were selected as a dependent variable. Tablets were prepared by melt granulation technique and evaluated for various evaluation parameters. It was observed that concentration of melt binder had significant effect on Q(1), Q(4), n, and K Binder concentration 25% w/w was found optimum. Optimized formulation (F(7)) showed good similarity with theoretical profile of drug. The X(2) variable had a significant effect on dependent variables, and the X(1) variable had no significant effect on dependent variables.

本研究采用 3(2) 全因子设计法研究了 PEG 6000 作为熔融粘合剂的浓度和 HPMC K4M 与 PVP 的比例对盐酸唑吡坦控释片剂的影响:PVP 对酒石酸唑吡坦控释片剂的影响。选择 HPMC K4M 和 PVP K30 的比例(X(1))和熔融粘合剂的浓度(X(2))为自变量,1 小时(Q(1))、4 小时(Q(4))、8 小时(Q(8))的药物释放量、扩散系数(n)和释放速率常数(K)为因变量。采用熔融造粒技术制备了片剂,并对各种评价参数进行了评估。结果表明,熔融粘合剂的浓度对 Q(1)、Q(4)、n 和 K 有显著影响。优化配方(F(7))与药物的理论曲线非常相似。X(2) 变量对因变量有显著影响,而 X(1) 变量对因变量没有显著影响。
{"title":"Formulation and evaluation of controlled-release tablet of zolpidem tartrate by melt granulation technique.","authors":"Shailesh T Prajapati, Amit N Patel, Chhagan N Patel","doi":"10.5402/2011/208394","DOIUrl":"10.5402/2011/208394","url":null,"abstract":"<p><p>The present investigation describes the influence of the concentration of PEG 6000 as a melt binder and ratio of HPMC K4M : PVP on Zolpidem tartrate controlled-release tablet formulations using 3(2) full factorial design. The ratio of HPMC K4M and PVP K30 (X(1)) and the concentration of melt binder (X(2)) were selected as independent variables, and drug release at 1 hr (Q(1)), 4 hr (Q(4)), 8 hr (Q(8)), diffusion coefficient (n), and release rate constant (K) were selected as a dependent variable. Tablets were prepared by melt granulation technique and evaluated for various evaluation parameters. It was observed that concentration of melt binder had significant effect on Q(1), Q(4), n, and K Binder concentration 25% w/w was found optimum. Optimized formulation (F(7)) showed good similarity with theoretical profile of drug. The X(2) variable had a significant effect on dependent variables, and the X(1) variable had no significant effect on dependent variables.</p>","PeriodicalId":14802,"journal":{"name":"ISRN Pharmaceutics","volume":"2011 ","pages":"208394"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263716/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30505267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study on HIF-1α Gene Translation in Psoriatic Epidermis with the Topical Treatment of Capsaicin Ointment. 辣椒素软膏局部治疗银屑病表皮HIF-1α基因翻译的研究
Pub Date : 2011-01-01 Epub Date: 2011-06-22 DOI: 10.5402/2011/821874
Chun-Shui Yu

Objective. To investigate the mechanism of capsaicin in treating active psoriasis vulgaris. Methods. HIF-1α gene translation in active psoriatic lesions before and after 21-day treatment with capsaicin ointment was detected by in situ hybridization. Results. There was positive staining of HIF-1α gene in all the layers of psoriatic epidermis (100.0%) before the treatment with capsaicin ointment, but the dyeing in epidermis were reduced obviously (22.2%) after the treatment for 21 days. Conclusion. HIF-1α gene translation in psoriatic epidermis was downregulated after capsaicin treatment for 21 days.

目标。探讨辣椒素治疗活动性寻常型银屑病的作用机制。方法。应用原位杂交技术检测辣椒素软膏治疗银屑病活动性病变前后HIF-1α基因的翻译情况。结果。辣椒素软膏治疗前,银屑病表皮各层HIF-1α基因染色阳性(100.0%),但治疗21 d后表皮染色明显减少(22.2%)。结论。辣椒素处理21天后,银屑病表皮HIF-1α基因翻译下调。
{"title":"Study on HIF-1α Gene Translation in Psoriatic Epidermis with the Topical Treatment of Capsaicin Ointment.","authors":"Chun-Shui Yu","doi":"10.5402/2011/821874","DOIUrl":"https://doi.org/10.5402/2011/821874","url":null,"abstract":"<p><p>Objective. To investigate the mechanism of capsaicin in treating active psoriasis vulgaris. Methods. HIF-1α gene translation in active psoriatic lesions before and after 21-day treatment with capsaicin ointment was detected by in situ hybridization. Results. There was positive staining of HIF-1α gene in all the layers of psoriatic epidermis (100.0%) before the treatment with capsaicin ointment, but the dyeing in epidermis were reduced obviously (22.2%) after the treatment for 21 days. Conclusion. HIF-1α gene translation in psoriatic epidermis was downregulated after capsaicin treatment for 21 days.</p>","PeriodicalId":14802,"journal":{"name":"ISRN Pharmaceutics","volume":"2011 ","pages":"821874"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/821874","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30505613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Two new cytotoxic candidaspongiolides from an indonesian sponge. 从印度尼西亚海绵中提取的两种新的细胞毒性念珠菌内酯。
Pub Date : 2011-01-01 Epub Date: 2011-07-18 DOI: 10.5402/2011/852619
Agus Trianto, Idam Hermawan, Toshimasa Suzuka, Junichi Tanaka

Marine sponges have been recognized as potentially rich sources of various bioactive molecules. In our continuing search for new secondary metabolites from Indonesian marine invertebrates, we collected a sponge, whose extract showed cytotoxicity against cultured cells at 0.1 μg/mL. Purification of the extract yielded two new macrolides 2 and 3 along with known candidaspongiolide (1). The structures for compounds 2 and 3 were elucidated by spectral analysis ((1)H, (13)C, COSY, HMQC, HMBC) and by comparison of their NMR data with those of 1. Compounds 2 and 3 exhibited a little more potent cytotoxicity (IC(50) 4.7 and 19 ng/mL) than that (IC(50) 37 ng/mL) of candidaspongiolide (1) against NBT-T2 cells.

海洋海绵被认为是各种生物活性分子的潜在丰富来源。在我们继续从印度尼西亚海洋无脊椎动物中寻找新的次生代谢物的过程中,我们收集了一种海绵,其提取物在0.1 μg/mL时对培养细胞具有细胞毒性。纯化后得到两个新的大环内酯2和3,以及已知的假木丝桃内酯(1)。化合物2和3的结构通过光谱分析((1)H, (13)C, COSY, HMQC, HMBC)和它们与1的NMR数据进行了比较。化合物2和3对NBT-T2细胞的细胞毒性(IC(50) 4.7和19 ng/mL)略高于候选藤内酯(1)(IC(50) 37 ng/mL)。
{"title":"Two new cytotoxic candidaspongiolides from an indonesian sponge.","authors":"Agus Trianto,&nbsp;Idam Hermawan,&nbsp;Toshimasa Suzuka,&nbsp;Junichi Tanaka","doi":"10.5402/2011/852619","DOIUrl":"https://doi.org/10.5402/2011/852619","url":null,"abstract":"<p><p>Marine sponges have been recognized as potentially rich sources of various bioactive molecules. In our continuing search for new secondary metabolites from Indonesian marine invertebrates, we collected a sponge, whose extract showed cytotoxicity against cultured cells at 0.1 μg/mL. Purification of the extract yielded two new macrolides 2 and 3 along with known candidaspongiolide (1). The structures for compounds 2 and 3 were elucidated by spectral analysis ((1)H, (13)C, COSY, HMQC, HMBC) and by comparison of their NMR data with those of 1. Compounds 2 and 3 exhibited a little more potent cytotoxicity (IC(50) 4.7 and 19 ng/mL) than that (IC(50) 37 ng/mL) of candidaspongiolide (1) against NBT-T2 cells.</p>","PeriodicalId":14802,"journal":{"name":"ISRN Pharmaceutics","volume":"2011 ","pages":"852619"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/852619","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30505615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Development and Validation of a HPLC and an UV Spectrophotometric Methods for Determination of Dexibuprofen in Pharmaceutical Preparations. 高效液相色谱法和紫外分光光度法测定药物制剂中德西布洛芬含量的建立与验证。
Pub Date : 2011-01-01 Epub Date: 2011-07-05 DOI: 10.5402/2011/948314
Selvadurai Muralidharan, Subramania Nainar Meyyanathan

A high-performance liquid chromatographic (HPLC) and a ultraviolet (UV) methods were developed and validated for the quantitative determination of Dexibuprofen (DI) in pharmaceutical dosage form. HPLC was carried out by reversed phase technique on a RP-18 column with a mobile phase composed of acetonitrile and 0.5% triethylamine (pH 7.5 adjusted with orthophosphoric acid (30 : 70, v/v)). UV method was performed with the λ max at 222.0 nm. Both the methods showed good linearity, reproducibility and precision. No spectral or chromatographic interferences from the tablet excipients were found in UV and HPLC. The method was successfully applied to commercial DEXIFEN tablets. Validation parameters such as linearity, precision, accuracy, and specificity were determined. The proposed method could be applicable for routine analysis of DI and monitoring of the quality of marketed drugs.

建立了高效液相色谱法(HPLC)和紫外分光光度法(UV)测定药物剂型德西布洛芬(DI)的方法,并进行了验证。HPLC色谱柱为RP-18,流动相为乙腈和0.5%三乙胺(pH 7.5,正磷酸调节pH (30:70, v/v))。紫外分光光度法,λ max在222.0 nm。两种方法均具有良好的线性、重现性和精密度。在紫外和高效液相色谱中未发现片剂辅料的光谱和色谱干扰。该方法成功地应用于市售DEXIFEN片。确定了验证参数,如线性、精密度、准确度和特异性。该方法可用于DI的常规分析和上市药品的质量监测。
{"title":"Development and Validation of a HPLC and an UV Spectrophotometric Methods for Determination of Dexibuprofen in Pharmaceutical Preparations.","authors":"Selvadurai Muralidharan,&nbsp;Subramania Nainar Meyyanathan","doi":"10.5402/2011/948314","DOIUrl":"https://doi.org/10.5402/2011/948314","url":null,"abstract":"<p><p>A high-performance liquid chromatographic (HPLC) and a ultraviolet (UV) methods were developed and validated for the quantitative determination of Dexibuprofen (DI) in pharmaceutical dosage form. HPLC was carried out by reversed phase technique on a RP-18 column with a mobile phase composed of acetonitrile and 0.5% triethylamine (pH 7.5 adjusted with orthophosphoric acid (30 : 70, v/v)). UV method was performed with the λ max at 222.0 nm. Both the methods showed good linearity, reproducibility and precision. No spectral or chromatographic interferences from the tablet excipients were found in UV and HPLC. The method was successfully applied to commercial DEXIFEN tablets. Validation parameters such as linearity, precision, accuracy, and specificity were determined. The proposed method could be applicable for routine analysis of DI and monitoring of the quality of marketed drugs.</p>","PeriodicalId":14802,"journal":{"name":"ISRN Pharmaceutics","volume":"2011 ","pages":"948314"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/948314","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30505617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Pharmacokinetic Compatibility Study of Lidocaine with EXPAREL in Yucatan Miniature Pigs. 利多卡因与EXPAREL在尤卡坦小型猪体内的药动学相容性研究。
Pub Date : 2011-01-01 Epub Date: 2011-12-27 DOI: 10.5402/2011/582351
Brigitte M Richard, Douglas E Rickert, Dannette Doolittle, Amy Mize, Jason Liu, Charles F Lawson

We explored the potential for EXPAREL to interact with lidocaine. Sixty (60) male Yucatan Swine were randomized into 20 groups (N = 3/group). EXPAREL (2 or 4 mg/kg) and/or lidocaine HCl solution 1% or 2% (with epinephrine 1 : 200,000) were injected subcutaneously along a 5 cm virtual incision line. The effects on the pharmacokinetics of bupivacaine and lidocaine were examined when 5, 10, 20, and 40 minutes had passed between administration of lidocaine and EXPAREL. Systemic exposure to lidocaine was increased (AUC(0-24 hr) by 48%; C(max) by 1,640%) when lidocaine (4 mg/kg) was followed 5 minutes later by EXPAREL (4 mg/kg) compared to lidocaine administered alone. Plasma bupivacaine was increased (AUC(0-24 hr) by 50-95%; C(max) by 67-1,000%) when lidocaine (4 mg/kg) was followed 5 or 10 minutes later by EXPAREL (4 mg/kg) compared to EXPAREL alone. While EXPAREL should not be admixed with lidocaine, this study shows that local administration of EXPAREL after at least 20 minutes following local administration of lidocaine did not increase the release of either drug.

我们探索了EXPAREL与利多卡因相互作用的潜力。选用60头尤卡坦公猪,随机分为20组,每组3头。EXPAREL(2或4mg /kg)和/或利多卡因盐酸溶液1%或2%(含肾上腺素1:20万)沿5cm虚拟切口线皮下注射。分别在给药时间间隔5、10、20、40 min时观察布比卡因和利多卡因药代动力学的变化。全身暴露于利多卡因(AUC)(0-24小时)增加48%;与单独给药利多卡因相比,在利多卡因(4 mg/kg) 5分钟后再给药EXPAREL (4 mg/kg)时,C(max)降低了1640%。血浆布比卡因(AUC)(0-24小时)增加50-95%;当利多卡因(4mg /kg)后5分钟或10分钟后再使用EXPAREL (4mg /kg)时,与单独使用EXPAREL相比,C(最大)降低67- 10000%。虽然EXPAREL不应与利多卡因混合使用,但本研究表明,在局部给药利多卡因后至少20分钟局部给药EXPAREL不会增加两种药物的释放。
{"title":"Pharmacokinetic Compatibility Study of Lidocaine with EXPAREL in Yucatan Miniature Pigs.","authors":"Brigitte M Richard,&nbsp;Douglas E Rickert,&nbsp;Dannette Doolittle,&nbsp;Amy Mize,&nbsp;Jason Liu,&nbsp;Charles F Lawson","doi":"10.5402/2011/582351","DOIUrl":"https://doi.org/10.5402/2011/582351","url":null,"abstract":"<p><p>We explored the potential for EXPAREL to interact with lidocaine. Sixty (60) male Yucatan Swine were randomized into 20 groups (N = 3/group). EXPAREL (2 or 4 mg/kg) and/or lidocaine HCl solution 1% or 2% (with epinephrine 1 : 200,000) were injected subcutaneously along a 5 cm virtual incision line. The effects on the pharmacokinetics of bupivacaine and lidocaine were examined when 5, 10, 20, and 40 minutes had passed between administration of lidocaine and EXPAREL. Systemic exposure to lidocaine was increased (AUC(0-24 hr) by 48%; C(max) by 1,640%) when lidocaine (4 mg/kg) was followed 5 minutes later by EXPAREL (4 mg/kg) compared to lidocaine administered alone. Plasma bupivacaine was increased (AUC(0-24 hr) by 50-95%; C(max) by 67-1,000%) when lidocaine (4 mg/kg) was followed 5 or 10 minutes later by EXPAREL (4 mg/kg) compared to EXPAREL alone. While EXPAREL should not be admixed with lidocaine, this study shows that local administration of EXPAREL after at least 20 minutes following local administration of lidocaine did not increase the release of either drug.</p>","PeriodicalId":14802,"journal":{"name":"ISRN Pharmaceutics","volume":"2011 ","pages":"582351"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/582351","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30505772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
Water-soluble Fraction of Abelmoschus esculentus L Interacts with Glucose and Metformin Hydrochloride and Alters Their Absorption Kinetics after Coadministration in Rats. 大鼠同时服用葡萄糖和盐酸二甲双胍后,枸杞子水溶性馏分与葡萄糖和盐酸二甲双胍相互作用并改变其吸收动力学
Pub Date : 2011-01-01 Epub Date: 2011-09-11 DOI: 10.5402/2011/260537
Hajera Khatun, Ajijur Rahman, Mohitosh Biswas, Anwar Ul Islam

This study was done to investigate the effects of water-soluble fraction (WSF) of the fruits of Abelmoschus esculentus L (okra/lady's fingers) on absorption of oral glucose as well as metformin from the gastrointestinal tract in the Long Evans rats. WSF of A. esculentus significantly (P < 0.05) reduced the absorption of glucose as studied in the 24 hrs fasting rats. The effect of WSF of A. esculentus on metformin absorption was studied in alloxan-induced diabetic rats. Significant differences (P < 0.05) were observed in the average blood glucose level from 2 to 24 hours after metformin therapy in presence (33.6 to 34.2 mmol/L) or absence (15.2 to 20.2 mmol/L) of oral WSF of A. esculentus. In both of the experiments, Na-carboxymethylcellulose (CMC) was used as positive control. The results of this study indicate that A. esculentus may improve glycemic control but should not be taken concurrently with metformin hydrochloride in controlling diabetes mellitus.

本研究旨在探讨秋葵果实的水溶性成分(WSF)对 Long Evans 大鼠胃肠道吸收口服葡萄糖和二甲双胍的影响。在对空腹 24 小时的大鼠进行的研究中,秋葵的 WSF 明显(P < 0.05)减少了葡萄糖的吸收。对阿脲诱导的糖尿病大鼠进行了研究,结果表明艾叶WSF对二甲双胍的吸收有影响。在二甲双胍存在(33.6 至 34.2 mmol/L)或不存在(15.2 至 20.2 mmol/L)的情况下,观察到二甲双胍治疗后 2 至 24 小时的平均血糖水平存在显著差异(P < 0.05)。在这两项实验中,均使用 Na-羧甲基纤维素(CMC)作为阳性对照。该研究结果表明,茜草可改善血糖控制,但在控制糖尿病时不应与盐酸二甲双胍同时服用。
{"title":"Water-soluble Fraction of Abelmoschus esculentus L Interacts with Glucose and Metformin Hydrochloride and Alters Their Absorption Kinetics after Coadministration in Rats.","authors":"Hajera Khatun, Ajijur Rahman, Mohitosh Biswas, Anwar Ul Islam","doi":"10.5402/2011/260537","DOIUrl":"10.5402/2011/260537","url":null,"abstract":"<p><p>This study was done to investigate the effects of water-soluble fraction (WSF) of the fruits of Abelmoschus esculentus L (okra/lady's fingers) on absorption of oral glucose as well as metformin from the gastrointestinal tract in the Long Evans rats. WSF of A. esculentus significantly (P < 0.05) reduced the absorption of glucose as studied in the 24 hrs fasting rats. The effect of WSF of A. esculentus on metformin absorption was studied in alloxan-induced diabetic rats. Significant differences (P < 0.05) were observed in the average blood glucose level from 2 to 24 hours after metformin therapy in presence (33.6 to 34.2 mmol/L) or absence (15.2 to 20.2 mmol/L) of oral WSF of A. esculentus. In both of the experiments, Na-carboxymethylcellulose (CMC) was used as positive control. The results of this study indicate that A. esculentus may improve glycemic control but should not be taken concurrently with metformin hydrochloride in controlling diabetes mellitus.</p>","PeriodicalId":14802,"journal":{"name":"ISRN Pharmaceutics","volume":"2011 ","pages":"260537"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263724/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30505767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formulation and optimization of sustained release Stavudine microspheres using response surface methodology. 响应面法优选司他夫定缓释微球。
Pub Date : 2011-01-01 Epub Date: 2011-06-28 DOI: 10.5402/2011/627623
Sanjay Dey, Soumen Pramanik, Ananya Malgope

The aim of the current study was to formulate and optimize the formulation on the basis of in vitro performance of microsphere. A 3(2) full factorial design was employed to study the effect of independent variables, polymer-to-drug ratio (X(1)) and stirring speed (X(2)), on dependent variables, encapsulation efficiency, particle size, and time to 80% drug release. The best batch exhibited a high entrapment efficiency of 70% and mean particle size 290 μm. The drug release was also sustained for more than 12 hours. The study helped in finding the optimum formulation with excellent sustained drug release.

本研究的目的是在考察微球体外性能的基础上对其配方进行优选。采用3(2)全因子设计研究了自变量聚合物与药物比(X(1))和搅拌速度(X(2))对因变量包封效率、粒径和药物释放时间(80%)的影响。最佳粒径为290 μm,包封效率为70%。药物释放也持续12小时以上。该研究有助于寻找具有良好缓释效果的最佳配方。
{"title":"Formulation and optimization of sustained release Stavudine microspheres using response surface methodology.","authors":"Sanjay Dey,&nbsp;Soumen Pramanik,&nbsp;Ananya Malgope","doi":"10.5402/2011/627623","DOIUrl":"https://doi.org/10.5402/2011/627623","url":null,"abstract":"<p><p>The aim of the current study was to formulate and optimize the formulation on the basis of in vitro performance of microsphere. A 3(2) full factorial design was employed to study the effect of independent variables, polymer-to-drug ratio (X(1)) and stirring speed (X(2)), on dependent variables, encapsulation efficiency, particle size, and time to 80% drug release. The best batch exhibited a high entrapment efficiency of 70% and mean particle size 290 μm. The drug release was also sustained for more than 12 hours. The study helped in finding the optimum formulation with excellent sustained drug release.</p>","PeriodicalId":14802,"journal":{"name":"ISRN Pharmaceutics","volume":"2011 ","pages":"627623"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/627623","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30506740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 44
Preparation and characterisation of highly loaded fluorescent chitosan nanoparticles. 高负载荧光壳聚糖纳米颗粒的制备与表征。
Pub Date : 2011-01-01 Epub Date: 2011-11-17 DOI: 10.5402/2011/246162
Haliza Katas, Chan Mui Wen

Chitosan (CS) nanoparticles have been developed as a versatile drug delivery system to transport drugs, genes, proteins, and peptides into target sites. Demands on fluorescent nanoparticles have increased recently due to various applications in medical and stem-cell-based researches. In this study, fluorescent CS nanoparticles were prepared by a mild method, namely, complex coacervation. Entrapment efficiency of sulforhodamine (SR101) loaded into CS nanoparticles was investigated to evaluate their capacity in incorporating fluorescent molecule. Particle size of produced fluorescent nanoparticles was in the range of 600-700 nm, and their particle size was highly dependent on the CS molecular weight as well as concentration. A high entrapment efficiency of SR101 into CS nanoparticles could also be obtained when it was dissolved in methanol. In conclusion, highly loaded fluorescent CS nanoparticles could be easily prepared using complex coacervation method and therefore can be applied in various medical researches.

壳聚糖(CS)纳米颗粒是一种多功能的药物传递系统,可将药物、基因、蛋白质和肽输送到靶点。近年来,由于在医学和干细胞研究中的各种应用,对荧光纳米粒子的需求增加了。本研究采用一种温和的方法,即复合凝聚法制备了荧光CS纳米颗粒。研究了CS纳米粒子负载磺胺(SR101)的包封效率,以评价其与荧光分子的包封能力。制备的荧光纳米颗粒的粒径在600 ~ 700 nm之间,其粒径高度依赖于CS的分子量和浓度。当SR101溶解于甲醇中时,其在CS纳米颗粒中的包封效率也很高。综上所述,采用复合凝聚法制备高负载的荧光CS纳米颗粒,可应用于各种医学研究。
{"title":"Preparation and characterisation of highly loaded fluorescent chitosan nanoparticles.","authors":"Haliza Katas,&nbsp;Chan Mui Wen","doi":"10.5402/2011/246162","DOIUrl":"https://doi.org/10.5402/2011/246162","url":null,"abstract":"<p><p>Chitosan (CS) nanoparticles have been developed as a versatile drug delivery system to transport drugs, genes, proteins, and peptides into target sites. Demands on fluorescent nanoparticles have increased recently due to various applications in medical and stem-cell-based researches. In this study, fluorescent CS nanoparticles were prepared by a mild method, namely, complex coacervation. Entrapment efficiency of sulforhodamine (SR101) loaded into CS nanoparticles was investigated to evaluate their capacity in incorporating fluorescent molecule. Particle size of produced fluorescent nanoparticles was in the range of 600-700 nm, and their particle size was highly dependent on the CS molecular weight as well as concentration. A high entrapment efficiency of SR101 into CS nanoparticles could also be obtained when it was dissolved in methanol. In conclusion, highly loaded fluorescent CS nanoparticles could be easily prepared using complex coacervation method and therefore can be applied in various medical researches.</p>","PeriodicalId":14802,"journal":{"name":"ISRN Pharmaceutics","volume":"2011 ","pages":"246162"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263707/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30505766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Randomized, double-blind, and placebo-controlled trial of clenbuterol in denervated muscle atrophy. 盐酸克仑特罗治疗去神经肌肉萎缩的随机、双盲、安慰剂对照试验。
Pub Date : 2011-01-01 Epub Date: 2011-08-15 DOI: 10.5402/2011/981254
Guang-Liang Jiang, Yu-Dong Gu, Li-Yin Zhang, Li-Ying Shen, Cong Yu, Jian-Guang Xu

Objectives. β(2)-adrenergic agonists, such as clenbuterol, have been shown to promote the hypertrophy of healthy skeletal muscles and to ameliorate muscle wasting in a few pathological conditions in both animals and humans. We intended to investigate the clinical efficacy of clenbuterol on attenuating denervation-induced muscle atrophy. Methods. A double-blind, placebo-controlled, parallel, and randomized trial was employed. 71 patients, suffering from brachial plexus injuries, were given either clenbuterol (60 μg, bid) or placebo for 3 months. Before and at the end of the study, patients were given physical examinations, biopsies of biceps brachii, electromyograms (EMGs), and other laboratory tests. Results. Compared with placebo treatment, clenbuterol significantly mitigated the decreases in cross-sectional areas of type I and II muscle fibers and alleviated the reduction in fibrillation potential amplitudes, without any adverse effects. Conclusions. Clenbuterol safely ameliorated denervated muscle atrophy in this cohort; thus larger clinical studies are encouraged for this or other β(2) agonists on denervation-induced muscle atrophy.

目标。β(2)-肾上腺素能激动剂,如瘦肉精,已被证明可以促进健康骨骼肌的肥大,并改善动物和人类在一些病理条件下的肌肉萎缩。本研究旨在探讨盐酸克仑特罗减轻去神经支配性肌肉萎缩的临床疗效。方法。采用双盲、安慰剂对照、平行和随机试验。71例臂丛神经损伤患者分别给予盐酸克仑特罗(60 μg, bid)或安慰剂治疗3个月。在研究之前和结束时,对患者进行体格检查、肱二头肌活检、肌电图(emg)和其他实验室检查。结果。与安慰剂治疗相比,盐酸克仑特罗显著缓解了ⅰ型和ⅱ型肌纤维横截面面积的减少,减轻了纤颤电位幅度的减少,无不良反应。结论。盐酸克仑特罗在该队列中安全改善失神经性肌肉萎缩;因此,鼓励对这种或其他β(2)激动剂治疗去神经支配引起的肌肉萎缩进行更大规模的临床研究。
{"title":"Randomized, double-blind, and placebo-controlled trial of clenbuterol in denervated muscle atrophy.","authors":"Guang-Liang Jiang,&nbsp;Yu-Dong Gu,&nbsp;Li-Yin Zhang,&nbsp;Li-Ying Shen,&nbsp;Cong Yu,&nbsp;Jian-Guang Xu","doi":"10.5402/2011/981254","DOIUrl":"https://doi.org/10.5402/2011/981254","url":null,"abstract":"<p><p>Objectives. β(2)-adrenergic agonists, such as clenbuterol, have been shown to promote the hypertrophy of healthy skeletal muscles and to ameliorate muscle wasting in a few pathological conditions in both animals and humans. We intended to investigate the clinical efficacy of clenbuterol on attenuating denervation-induced muscle atrophy. Methods. A double-blind, placebo-controlled, parallel, and randomized trial was employed. 71 patients, suffering from brachial plexus injuries, were given either clenbuterol (60 μg, bid) or placebo for 3 months. Before and at the end of the study, patients were given physical examinations, biopsies of biceps brachii, electromyograms (EMGs), and other laboratory tests. Results. Compared with placebo treatment, clenbuterol significantly mitigated the decreases in cross-sectional areas of type I and II muscle fibers and alleviated the reduction in fibrillation potential amplitudes, without any adverse effects. Conclusions. Clenbuterol safely ameliorated denervated muscle atrophy in this cohort; thus larger clinical studies are encouraged for this or other β(2) agonists on denervation-induced muscle atrophy.</p>","PeriodicalId":14802,"journal":{"name":"ISRN Pharmaceutics","volume":"2011 ","pages":"981254"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/981254","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30505618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
期刊
ISRN Pharmaceutics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1